Inventor · disambiguated record
Jean-Charles Epinat
Also filed as: EPINAT JEAN-CHARLES
12 granted patents·10 pending applications·121 citations·filing 2003–2023
91Inventor score
Top patents by PatentIndex Score
22 records- 0195US7842489B2Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofCELLECTIS·Filed 2010·Granted Nov 30, 2010·63 cites·7 claims
- 0291US8530214B2Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2011·Granted Sep 10, 2013·13 cites·16 claims
- 0387US9315788B2Method for the generation of compact TALE-nucleases and uses thereofDUCHATEAU PHILIPPE·Filed 2012·Granted Apr 19, 2016·12 cites·33 claims
- 0485US11466291B2Sequential gene editing in primary immune cellsCELLECTIS·Filed 2017·Granted Oct 11, 2022·4 cites·27 claims
- 0583US8624000B2Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2012·Granted Jan 7, 2014·5 cites·14 claims
- 0683US8211685B2I-DmoI derivatives with enhanced activity at 37° C and use thereofEPINAT JEAN-CHARLES·Filed 2005·Granted Jul 3, 2012·10 cites·22 claims
- 0782US8697395B2Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2012·Granted Apr 15, 2014·4 cites·18 claims
- 0881US10087453B2Modified diatoms for biofuel productionCELLECTIS·Filed 2014·Granted Oct 2, 2018·4 cites·20 claims
- 0979US11674155B2Sequential gene editing in primary immune cellsCELLECTIS·Filed 2022·Granted Jun 13, 2023·0 cites·17 claims
- 1076US2023287454A1Sequential gene editing in primary immune cellsCELLECTIS·Filed 2023·Application pending·0 cites
- 1174US2022010292A1Method for the generation of compact tale-nucleases and uses thereofCELLECTIS·Filed 2021·Application pending·0 cites
- 1272US11136566B2Tale-protein scaffolds and uses thereofCELLECTIS·Filed 2019·Granted Oct 5, 2021·0 cites·17 claims
- 1370US8206965B2Hybrid and single chain meganucleases and use thereofARNOULD SYLVAIN·Filed 2003·Granted Jun 26, 2012·6 cites·15 claims
- 1462US11198856B2Method for the generation of compact tale-nucleases and uses thereofCELLECTIS·Filed 2016·Granted Dec 14, 2021·0 cites·22 claims
- 1562US2014121115A1Custom-made meganuclease and use thereofARNOULD SYLVAIN·Filed 2012·Application pending·0 cites
- 1662US2013203840A1Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofCELLECTIS SA·Filed 2012·Application pending·0 cites
- 1758US2011151539A1Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2011·Application pending·0 cites
- 1857US2006153826A1Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2004·Application pending·0 cites
- 1957US2006206949A1Custom-made meganuclease and use thereofARNOULD SYLVAIN·Filed 2004·Application pending·0 cites
- 2056US2012322689A1Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofEPINAT JEAN-CHARLES·Filed 2012·Application pending·0 cites
- 2152US2010151556A1Hybrid and single chain meganucleases and use thereofCELLECTIS·Filed 2009·Application pending·0 cites
- 2240US2013337454A1Method for increasing the efficiency of double-strand break-induced mutagenesisDUCHATEAU PHILIPPE·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →